• Most Popular
  • Most Shared

India Dr. Reddy's gets FDA nod for naproxen sodium

Tue Jul 31, 2007 10:51pm EDT

Stocks

   

Regulatory News

MUMBAI, Aug 1 (Reuters) - Indian drug maker Dr. Reddy's Laboratories Ltd. (REDY.BO) (RDY.N) has received approval from the U.S. Food and Drug Administration for naproxen sodium tablets, an anti-inflammatory drug, the regulator's Web site showed.

((Reporting by Rina Chandran, editing by John Mair; Reuters Messaging: rina.chandran.reuters.com@reuters.net; +91 22 6636 9251)) Keywords: REDDYS APPROVAL/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nBOM56262
Regulatory News


More from Reuters

Photo

Home prices flat after five months of gains

NEW YORK (Reuters) - U.S. home prices were unchanged in October, according to the widely watched Standard & Poor's/Case-Shiller indexes released on Tuesday, indicating stabilization in the hard-hit housing sector though the figures dashed hopes for a sixth straight monthly increase.

» More Top News
An employee swipes a customer's credit card through the card reader at a restaurant in Tokyo February 19, 2005.REUTERS/Issei Kato

Taking a swipe at credit cards

New legislation meant to protect consumers could be a "game changer" for the industry -- and not in a good way.  Full Article 

Economy
dealer shuffles a deck of cards during a poker game at a casino in Budapest September 15, 2009. REUTERS/Katoly Arvai

Placing their bets

Two IPO filings will test investors' appetite for risk that they probably would've avoided in the past year.  Full Article 

DEALS